This site is intended for healthcare professionals
News

Johnson & Johnson posts interim results from phase 1/IIa clinical trial of JNJ-78436735 to treat COVID-19.

Read time: 2 mins
Last updated:28th Sep 2020
Published:28th Sep 2020
Condition: Coronavirus/COVID-19 Infection
Type: drug
Register free for full access to medthority.com